Fidelity Investments
AUTL

Fidelity Investments’s Autolus Therapeutics AUTL Stock Holding History

Fidelity Investments’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,105,585
Closed -$16.2M – 5380
2025
Q2 		$16.2M Sell
7,105,585
-3,056,763
-30% -$5.05M ﹤0.01% 1753
2025
Q1 		$15.8M Sell
10,162,348
-5,469,922
-35% -$11.1M ﹤0.01% 1755
2024
Q4 		$36.7M Sell
15,632,270
-2,141,603
-12% -$7.24M ﹤0.01% 1507
2024
Q3 		$64.5M Buy
17,773,873
+5,478,706
+45% +$21.8M ﹤0.01% 1272
2024
Q2 		$42.8M Buy
12,295,167
+3,278,777
+36% +$14.1M ﹤0.01% 1368
2024
Q1 		$57.5M Buy
9,016,390
+9,014,165
+405,131% +$56.2M ﹤0.01% 1278
2023
Q4 		$14.3K Hold
2,225
– – ﹤0.01% 4110
2023
Q3 		$5.18K Buy
2,225
+1,092
+96% +$3.11K ﹤0.01% 4326
2023
Q2 		$2.7K Hold
1,133
– – ﹤0.01% 4521
2023
Q1 		$2.08K Hold
1,133
– – ﹤0.01% 4621
2022
Q4 		$2.15K Sell
1,133
-380,185
-100% -$961K ﹤0.01% 4494
2022
Q3 		$816K Buy
381,318
+1,133
+0.3% +$3.36K ﹤0.01% 2659
2022
Q2 		$1.08M Sell
380,185
-1,262,100
-77% -$3.84M ﹤0.01% 2658
2022
Q1 		$6.85M Hold
1,642,285
– – ﹤0.01% 2268
2021
Q4 		$8.52M Buy
1,642,285
+140,297
+9% +$842K ﹤0.01% 2174
2021
Q3 		$9.84M Sell
1,501,988
-568,500
-27% -$3.59M ﹤0.01% 2132
2021
Q2 		$13.7M Hold
2,070,488
– – ﹤0.01% 1987
2021
Q1 		$11.9M Buy
2,070,488
+1,957,721
+1,736% +$14.5M ﹤0.01% 1974
2020
Q4 		$1.01M Buy
112,767
+58,773
+109% +$626K ﹤0.01% 2522
2020
Q3 		$628K Sell
53,994
-34,014
-39% -$493K ﹤0.01% 2500
2020
Q2 		$1.41M Sell
88,008
-124,100
-59% -$1.38M ﹤0.01% 2345
2020
Q1 		$1.27M Hold
212,108
– – ﹤0.01% 2281
2019
Q4 		$2.8M Sell
212,108
-99,040
-32% -$1.3M ﹤0.01% 2178
2019
Q3 		$3.86M Sell
311,148
-62,652
-17% -$828K ﹤0.01% 2117
2019
Q2 		$6.02M Buy
+373,800
New +$8.36M ﹤0.01% 2038

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments's AUTL Position: Q3 2025 in Review

Fidelity Investments sold out of Autolus Therapeutics (AUTL) in Q3 2025, closing a stake of 7,105,585 shares — an estimated $16.2M sold.

Fidelity Investments first reported a position in AUTL in Q2 2019 and held it in 25 quarters. The position peaked at $64.5M in Q3 2024. 96 funds tracked by Wall St. Rank hold AUTL as of Q3 2025.

  • Fidelity Investments reported no remaining Autolus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 7,105,585 Autolus Therapeutics shares in Q3 2025, an estimated $16.2M.
  • Fidelity Investments first reported a position in Autolus Therapeutics in Q2 2019 and held it in 25 quarters.
  • Fidelity Investments's Autolus Therapeutics position peaked at $64.5M in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.